News for hackers. Stuff that matters.
Re:Goldman Sachs questions whether curing patients is a sust... by aaavl2821 on Friday April 13, 2018 @09:00AM (#16829534)
If the US were to make all drug R&D a public service they'd have to basically increase the current NIH budget from ~$30B to probably $150B

It may be nice in theory to have government manage drug R&D, but it is not practical. It's simply too expensive

Re:Goldman Sachs questions whether curing patients is a sust... by pjc50 on Friday April 13, 2018 @09:02AM (#16829556)
.. or a fifth of the military budget.

"It's not practical of the US to maintain the most expensive military in the world, it's simply too expensive" said nobody in Congress ever.

Re:Goldman Sachs questions whether curing patients is a sust... by Clubber on Friday April 13, 2018 @09:17AM (#16829666)
Eisenhower's warning of the military-industrial complex is still very much valid, nearly 60 years later.

Ike then counseled American citizens to be vigilant in monitoring the military-industrial complex.

https://www.history.com/this-day-in-history/eisenhower-warns...

Re:Goldman Sachs questions whether curing patients is a sust... by arca_vorago on Friday April 13, 2018 @10:22AM (#16830244)
It is also worth noting that the original speech called it the military industrial congressional complex. Indeed very relevant.
Re:Goldman Sachs questions whether curing patients is a sust... by magicalist on Friday April 13, 2018 @12:08PM (#16831311)
> or a fifth of the military budget

And less than the projected increase in the deficit this year due to tax cuts and spending increases

Re:Goldman Sachs questions whether curing patients is a sust... by aaavl2821 on Friday April 13, 2018 @10:42AM (#16830398)
Thats a false comparison. It's like saying "people spend $1,000 on iPhones. Why wouldn't they spend $1,000 on a pizza?"

Ability to pay and willingness to pay are very different concepts

Re:Goldman Sachs questions whether curing patients is a sust... by magicalist on Friday April 13, 2018 @12:06PM (#16831297)
> Thats a false comparison.

All your argument was that it's too expensive. Clearly it's not. If the manner in which the money is spent (or the feelings we'll have while sending it) is actually the limiting factor, you'll need to actually make that argument.

Re:Goldman Sachs questions whether curing patients is a sust... by jamroom on Friday April 13, 2018 @09:03AM (#16829564)
It's not too expensive - the US can easily afford $150B. We just have to decide that it's a priority and make it happen. Each year we some how find almost a trillion dollars for defense (more if you include "black budget") and no one blinks an eye.
Re:Goldman Sachs questions whether curing patients is a sust... by jrobn on Friday April 13, 2018 @09:22AM (#16829703)
I think the US is still stuck in the Cold War mentality of making military spending an “untouchable” cut. Meanwhile country infrastructure is falling apart and our equality gap is unprecedented. Sounds a lot like the USSR.
Re:Goldman Sachs questions whether curing patients is a sust... by tgb on Friday April 13, 2018 @09:16AM (#16829658)
It's not politically practical, but why would you expect that paying for the stuff we already pay for is too expensive?
Re:Goldman Sachs questions whether curing patients is a sust... by tgb on Friday April 13, 2018 @01:13PM (#16831912)
I'll assume that downvotes mean I wasn't clear: the US is currently spending that much ($150B apparently, I haven't checked) on R&D for drugs. It's just doing it through different means, presumably by paying higher insurance premiums and healthcare costs that end up going to drug companies to fund their R&D. If instead we payed that cost through taxes, then there's no theoretical reason why it would have to cost any more. So why would it be too expensive, given that we already pay that much via a different route? Of course, it's not politically expedient and won't happen anytime soon.